Compugen Company
Compugen is a drug and diagnostic discovery company, addressing important unmet therapeutic and diagnostic needs.
Founded Date:
1993-02-01
Technology:
Biologics
Investor Type:
Company
Funding Status:
IPO
Total Funding:
67400000.0
Employee Number:
51-100
Headquarters:
Tel Aviv, Tel Aviv, Israel
Last Funding Date:
2021-11-11
Investors Number:
3.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$10M to $50M
Investment Stage:
N/A
Number Of Exists:
N/A
Industry:
Early Drug Development